MMN is a rare immune-mediated demyelinating neuropathy that causes progressive, asymmetric weakness of the distal limbs with no objective sensory loss.1,2 MMN is treatable but, cannot be cured and disease progression depends on how long patients remain undiagnosed and untreated.1,2

Learn more about diagnosis and treatment of MMN:

References:

  1. Katirji B, Koontz D. Disorders of peripheral nerves. In: Daroff RB, Fenichel GM, Jankovic J, Mazziotta JC, eds. Bradley's Neurology in Clinical Practice. Vol 2. 6th ed. Philadelphia, PA: Saunders Elsevier; 2012:1915-2015.
  2. Vlam L, van der Pol W-L, Cats EA, et al. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol. 2012;8(1):48-58.
  3. Data on file, Baxter Healthcare Corporation. 2011.
The largest
controlled clinical
trail in Multifocal
Motor Neuropathy
to date3
View Study Design
Expand

Please expand for Indication and Detailed Important Safety Information.

Selected Important Safety Information about GAMMAGARD LIQUID
  • GAMMAGARD LIQUID can cause decreased kidney function or kidney failure, blood clots in the heart, brain, lungs or elsewhere in the body. Call your healthcare professional or go to your emergency department right away if you have: Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem. Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot.
  • Do not take GAMMAGARD LIQUID if you have a known history of a severe allergic reaction to IgG or other blood products.